Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial

BACKGROUND: Afghanistan's national guidelines recommend chloroquine for the treatment of Plasmodium vivax infection, the parasite responsible for the majority of its malaria burden. Chloroquine resistance in P. vivax is emerging in Asia. Therapeutic responses across Afghanistan have not been ev...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Awab, Ghulam Rahim, Pukrittayakamee, Sasithon, Imwong, Mallika, Dondorp, Arjen M, Woodrow, Charles J, Lee, Sue Jean, Day, Nicholas PJ, Singhasivanon, Pratap, White, Nicholas J, Kaker, Faizullah
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2010
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864284/
https://ncbi.nlm.nih.gov/pubmed/20409302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-9-105
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia